Circ_LAS1L regulates cardiac fibroblast activation, growth, and migration through miR-125b/SFRP5 pathway

Li-Ye Sun1, Jin-Chao Zhao2, Xiao-Ming Ge3

  • 1Department of Geratology, Yantai Yuhuangding Hospital, Yantai, China.

Insights

Circular RNAs (circRNAs) like circ_LAS1L inhibit fibrosis in acute myocardial infarction (AMI) by sponging miR-125b, promoting SFRP5 expression, and regulating cardiac fibroblast activity. This pathway offers a therapeutic target for myocardial fibrosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • RNA Biology

Background:

  • Circular RNAs (circRNAs) and microRNAs (miRNAs) are implicated in acute myocardial infarction (AMI).
  • miR-125b promotes fibrosis and is upregulated in cardiac fibroblasts (CFs).
  • The role of circRNAs in myocardial fibrosis remains underexplored.

Purpose of the Study:

  • To investigate the role of circ_LAS1L in myocardial fibrosis.
  • To elucidate the interaction between circ_LAS1L and miR-125b.
  • To determine the downstream effects of circ_LAS1L on cardiac fibroblast function.

Main Methods:

  • RNA immunoprecipitation (RIP) and pull-down assays to confirm binding.
  • Dual luciferase reporter gene assay to validate interaction.
  • Overexpression and siRNA transfection in cardiac fibroblasts (CFs).

Main Results:

  • circ_LAS1L directly binds to miR-125b.
  • circ_LAS1L overexpression inhibits CF proliferation, migration, and fibrosis markers (alpha-SMA, collagen I/III), while promoting apoptosis.
  • circ_LAS1L promotes SFRP5 expression, acting as a sponge for miR-125b.

Conclusions:

  • The circ_LAS1L/miR-125b/SFRP5 pathway regulates cardiac fibroblast biological functions.
  • circ_LAS1L acts as a tumor suppressor in myocardial fibrosis by inhibiting miR-125b.
  • This pathway provides a potential therapeutic strategy for myocardial fibrosis post-AMI.